CV · NASDAQ
CapsoVision (CV) Stock Price & Fundamentals
CapsoVision (CV) closed at $566.92 on Oct 9, 2026, down 0.02% from the previous close of $567.01.
Share price, past year
1Y +5.96%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $566.92 |
| Sep 30, 2026 | $569.05 |
| Aug 31, 2026 | $553.29 |
| Jul 31, 2026 | $554.80 |
| Jun 30, 2026 | $575.37 |
| May 29, 2026 | $538.28 |
| Apr 30, 2026 | $513.51 |
| Mar 31, 2026 | $532.13 |
| Feb 27, 2026 | $555.36 |
| Jan 30, 2026 | $556.30 |
| Dec 31, 2025 | $548.18 |
| Nov 28, 2025 | $575.29 |
| Oct 31, 2025 | $545.07 |
Key statistics
- Market cap
- $28.36B
- P/E (TTM)
- 178.3
- EPS (TTM)
- $3.18
- Revenue (TTM)
- $13.89M
- Net income (TTM)
- −$29.83M
- Shares outstanding
- 50M
- Dividend yield
- —
- 52-week range
- $501.08 – $584.78
CapsoVision's market cap is $28.36B, based on a share price of $566.92 and 50M shares outstanding as of Jun 30, 2026.
Financials
CapsoVision reported revenue of $13.55M for fiscal 2025, up 15.29% from fiscal 2024.
CapsoVision reported a net loss of $25.32M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $13.55M | +15.3% | −$25.32M | −186.8% | −$1.03 | −$22.95M |
| FY2024ended Dec 31, 2024 | $11.76M | — | −$19.90M | −169.3% | −$9.85 | −$20.24M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $3.64M | −$7.48M | −$0.15 |
| Q1 FY2026ended Mar 31, 2026 | $2.79M | −$7.03M | −$0.15 |
| Q4 FY2025ended Dec 31, 2025 | $3.92M | −$7.39M | $3.65 |
| Q3 FY2025ended Sep 30, 2025 | $3.54M | −$7.92M | −$0.17 |
| Q2 FY2025ended Jun 30, 2025 | $3.32M | −$4.63M | −$2.02 |
| Q1 FY2025ended Mar 31, 2025 | $2.78M | −$5.38M | −$2.49 |
| Q3 FY2024ended Sep 30, 2024 | $2.97M | −$5.79M | −$2.79 |
| Q2 FY2024ended Jun 30, 2024 | $2.84M | — | −$2.58 |
Company profile
- Name
- CapsoVision, Inc
- Ticker
- CV
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Electromedical & Electrotherapeutic Apparatus
- Headquarters
- 18805 Cox Avenue Suite 250, Saratoga, CA 95070
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001378325
Recent SEC filings
- Sep 28, 2026
- Sep 18, 2026
- Aug 18, 2026
- Aug 13, 2026
- Aug 13, 2026
- Jul 2, 2026
- Jun 12, 2026
- May 14, 2026
Frequently asked questions
What is CapsoVision's stock price?
CapsoVision (CV) closed at $566.92 on Oct 9, 2026, down 0.02% from the previous close of $567.01.
What is CapsoVision's market cap?
CapsoVision's market cap is $28.36B, based on a share price of $566.92 and 50M shares outstanding as of Jun 30, 2026.
How much revenue does CapsoVision make?
CapsoVision reported revenue of $13.55M for fiscal 2025, up 15.29% from fiscal 2024.
What is CV's P/E ratio?
CapsoVision's price-to-earnings ratio is 178.3, based on trailing twelve-month diluted EPS of $3.18.
Does CapsoVision pay a dividend?
CapsoVision's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from CapsoVision, Inc's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures